ArticleContemporary oncology (Poznan, Poland)2022

Prognostic values of myeloid differentiation factor 88 (MYD88) and transducin (β)-like receptor 1 (TBLR1) expression in tissues of diffuse large B-cell non-Hodgkin lymphoma patients - an immunohistochemical study.

Asmaa Hussein Mohamed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.